Zacks Research Downgrades UnitedHealth Group (NYSE:UNH) to Hold

Key Points

• Zacks Research downgraded UnitedHealth Group from “strong buy” to “hold” and estimated fourth-quarter 2027 earnings at $4.06 per share.
• Despite the downgrade, broader analyst sentiment remains positive, with a consensus “moderate buy” rating and an average price target of $456.56, compared with the stock’s $375.95 opening price.
• UnitedHealth recently exceeded quarterly expectations, reporting $6.38 in earnings per share versus the $4.94 consensus estimate and revenue of $112.03 billion; institutional investors own 87.86% of the company.

UnitedHealth Group (NYSE:UNH - Get Free Report) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating in a research note issued on Monday, Zacks reports. Zacks Research also issued estimates for UnitedHealth Group's Q4 2027 earnings at $4.06 EPS.

A number of other analysts also recently weighed in on UNH. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Barclays increased their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a research report on Monday, July 20th. DA Davidson set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. HC Wainwright set a $492.00 price target on shares of UnitedHealth Group in a report on Wednesday, May 27th. Finally, Sanford C. Bernstein restated an "outperform" rating on shares of UnitedHealth Group in a research note on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $456.56.

UnitedHealth Group Stock Performance

NYSE UNH opened at $375.95 on Monday. The company has a market capitalization of $337.46 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 1.44 and a beta of 0.61. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a fifty day simple moving average of $406.84 and a 200 day simple moving average of $369.73. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts expect that UnitedHealth Group will post 19.82 EPS for the current year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently modified their holdings of the stock. BlackRock Inc. increased its position in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. State Street Corp grew its stake in shares of UnitedHealth Group by 2.5% during the 4th quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate's stock worth $14,931,592,000 after acquiring an additional 1,119,834 shares during the period. Capital World Investors raised its stake in UnitedHealth Group by 3.8% in the 4th quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate's stock valued at $7,457,723,000 after acquiring an additional 824,120 shares during the period. Capital International Investors boosted its position in UnitedHealth Group by 6.6% during the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate's stock worth $6,158,734,000 after purchasing an additional 1,155,162 shares during the period. Finally, Norges Bank purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $4,376,167,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s raised fiscal 2026 earnings outlook, recent revenue and EPS beats, and stable 86.7% medical loss ratio are supporting the bullish case. Analysts have reportedly increased estimates, while the company’s free-cash-flow yield and valuation may attract long-term investors. UnitedHealth: Lagging, But An Upbeat 2026 Outlook Helps Clear The Path
• Positive Sentiment: UnitedHealth’s use of artificial intelligence across its insurance operations is being highlighted as a potential long-term efficiency and growth driver, reinforcing the company’s competitive positioning. How UnitedHealth Leads the AI Revolution in the Insurance Industry
• Neutral Sentiment: UnitedHealth will report third-quarter 2026 results before the market opens on October 13. The date provides a future catalyst, but does not change current earnings expectations. UnitedHealth Group Announces Earnings Release Date
• Neutral Sentiment: UBS expects UnitedHealth’s earnings-growth outlook to remain broadly intact, although investors continue to focus on Medicare Advantage trends ahead of the next results. UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says
• Negative Sentiment: UnitedHealth is selling an interest in underperforming WellMed clinics in Florida to TPG, citing the need for local operating expertise rather than cash. The transaction underscores cost pressures, restrictive Medicare Advantage payments, and the operational reset at Optum Health—issues that are weighing on near-term sentiment. UnitedHealth Partners with TPG to Strengthen Underperforming Florida Clinics
• Negative Sentiment: The September 14 ex-dividend date may create short-term technical pressure, though shareholders of record remain eligible for the $2.32-per-share cash dividend payable September 22. UnitedHealth Group Dividend Analysis

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.